NCT00160745View on ClinicalTrials.gov

Rosuvastatin and Renal Endothelial Function

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 2006

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin

Trial Locations (1)

91054

CRC, Medizinische Klinik 4 - Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT00160745 - Rosuvastatin and Renal Endothelial Function | Biotech Hunter | Biotech Hunter